APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Receptor ROR Gamma

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nuclear Receptor ROR Gamma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025196 pages

Choose your research edition.

Industry ResearchNuclear Receptor ROR Gamma Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Receptor ROR Gamma Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Nuclear Receptor ROR Gamma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Receptor ROR Gamma Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Receptor ROR Gamma Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Nuclear Receptor ROR Gamma market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nuclear Receptor ROR Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nuclear Receptor ROR Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nuclear Receptor ROR Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nuclear Receptor ROR Gamma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nuclear Receptor ROR Gamma include Eli Lilly, GlaxoSmithKline Plc, Biogen Inc, Beijing Hanmi Pharmaceutical, Reata Pharmaceuticals Inc, Phenex Pharmaceuticals AG, Pfizer Inc, Lead Pharma Holding BV and Glenmark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nuclear Receptor ROR Gamma market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nuclear Receptor ROR Gamma and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nuclear Receptor ROR Gamma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nuclear Receptor ROR Gamma market size, projected growth trends, production technologies, key applications, and end-use industries.

Nuclear Receptor ROR Gamma Segment by Company

Eli Lilly

GlaxoSmithKline Plc

Biogen Inc

Beijing Hanmi Pharmaceutical

Reata Pharmaceuticals Inc

Phenex Pharmaceuticals AG

Pfizer Inc

Lead Pharma Holding BV

Glenmark Pharmaceuticals

Genfit SA

Eurofins Advinus

Celgene Corp

Bristol-Myers Squibb Company

Brickell Biotech Inc

Aurigene Discovery Technologies

AbbVie Inc

Nuclear Receptor ROR Gamma Segment by Type

BBI-6000

R&D Progress

INV-17

IMU-366

GSK-2981278

GRC-39815Action

Others

Nuclear Receptor ROR Gamma Segment by Application

Axial Spondyloarthritis

Asthma

Breast Cancer

Chronic Obstructive Pulmonary Disease

Others

Nuclear Receptor ROR Gamma Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Receptor ROR Gamma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Receptor ROR Gamma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Receptor ROR Gamma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nuclear Receptor ROR Gamma market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nuclear Receptor ROR Gamma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nuclear Receptor ROR Gamma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nuclear Receptor ROR Gamma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nuclear Receptor ROR Gamma Industry Trends Table 2. Nuclear Receptor ROR Gamma Industry Drivers Table 3. Nuclear Receptor ROR Gamma Industry Opportunities and Challenges Table 4. Nuclear Receptor ROR Gamma Industry Restraints Table 5. Global Nuclear Receptor ROR Gamma Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nuclear Receptor ROR Gamma Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nuclear Receptor ROR Gamma Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers Table 9. Global Nuclear Receptor ROR Gamma Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Nuclear Receptor ROR Gamma Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nuclear Receptor ROR Gamma Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nuclear Receptor ROR Gamma Manufacturers, Product Type & Application Table 13. Global Nuclear Receptor ROR Gamma Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nuclear Receptor ROR Gamma by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of BBI-6000 Table 17. Major Manufacturers of R&D Progress Table 18. Major Manufacturers of INV-17 Table 19. Major Manufacturers of IMU-366 Table 20. Major Manufacturers of GSK-2981278 Table 21. Major Manufacturers of GRC-39815Action Table 22. Major Manufacturers of Others Table 23. Global Nuclear Receptor ROR Gamma Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Nuclear Receptor ROR Gamma Sales by Type (2021-2026) & (W Units) Table 25. Global Nuclear Receptor ROR Gamma Sales by Type (2027-2032) & (W Units) Table 26. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2021-2026) Table 27. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2027-2032) Table 28. Global Nuclear Receptor ROR Gamma Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 29. Global Nuclear Receptor ROR Gamma Revenue by Type (2021-2026) & (W Units) Table 30. Global Nuclear Receptor ROR Gamma Revenue by Type (2027-2032) & (W Units) Table 31. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2021-2026) Table 32. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Axial Spondyloarthritis Table 34. Major Manufacturers of Asthma Table 35. Major Manufacturers of Breast Cancer Table 36. Major Manufacturers of Chronic Obstructive Pulmonary Disease Table 37. Major Manufacturers of Others Table 38. Global Nuclear Receptor ROR Gamma Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 39. Global Nuclear Receptor ROR Gamma Sales by Application (2021-2026) & (W Units) Table 40. Global Nuclear Receptor ROR Gamma Sales by Application (2027-2032) & (W Units) Table 41. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2021-2026) Table 42. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2027-2032) Table 43. Global Nuclear Receptor ROR Gamma Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 44. Global Nuclear Receptor ROR Gamma Revenue by Application (2021-2026) & (W Units) Table 45. Global Nuclear Receptor ROR Gamma Revenue by Application (2027-2032) & (W Units) Table 46. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2021-2026) Table 47. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2027-2032) Table 48. Global Nuclear Receptor ROR Gamma Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 49. Global Nuclear Receptor ROR Gamma Sales by Region (2021-2026) & (W Units) Table 50. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2021-2026) Table 51. Global Nuclear Receptor ROR Gamma Sales Forecasted by Region (2027-2032) & (W Units) Table 52. Global Nuclear Receptor ROR Gamma Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Nuclear Receptor ROR Gamma Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. North America Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 55. North America Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 56. Europe Nuclear Receptor ROR Gamma Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. Europe Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 58. Europe Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 59. Asia Pacific Nuclear Receptor ROR Gamma Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 60. Asia Pacific Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 61. Asia Pacific Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 62. South America, Middle East and Africa Nuclear Receptor ROR Gamma Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 63. South America, Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2021-2026) & (W Units) Table 64. South America, Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2027-2032) & (W Units) Table 65. Global Nuclear Receptor ROR Gamma Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Nuclear Receptor ROR Gamma Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Nuclear Receptor ROR Gamma Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2021-2026) Table 69. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2027-2032) Table 70. Eli Lilly Company Information Table 71. Eli Lilly Business Overview Table 72. Eli Lilly Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Eli Lilly Nuclear Receptor ROR Gamma Product Portfolio Table 74. Eli Lilly Recent Development Table 75. GlaxoSmithKline Plc Company Information Table 76. GlaxoSmithKline Plc Business Overview Table 77. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Portfolio Table 79. GlaxoSmithKline Plc Recent Development Table 80. Biogen Inc Company Information Table 81. Biogen Inc Business Overview Table 82. Biogen Inc Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Biogen Inc Nuclear Receptor ROR Gamma Product Portfolio Table 84. Biogen Inc Recent Development Table 85. Beijing Hanmi Pharmaceutical Company Information Table 86. Beijing Hanmi Pharmaceutical Business Overview Table 87. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Portfolio Table 89. Beijing Hanmi Pharmaceutical Recent Development Table 90. Reata Pharmaceuticals Inc Company Information Table 91. Reata Pharmaceuticals Inc Business Overview Table 92. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Portfolio Table 94. Reata Pharmaceuticals Inc Recent Development Table 95. Phenex Pharmaceuticals AG Company Information Table 96. Phenex Pharmaceuticals AG Business Overview Table 97. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Portfolio Table 99. Phenex Pharmaceuticals AG Recent Development Table 100. Pfizer Inc Company Information Table 101. Pfizer Inc Business Overview Table 102. Pfizer Inc Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Pfizer Inc Nuclear Receptor ROR Gamma Product Portfolio Table 104. Pfizer Inc Recent Development Table 105. Lead Pharma Holding BV Company Information Table 106. Lead Pharma Holding BV Business Overview Table 107. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Portfolio Table 109. Lead Pharma Holding BV Recent Development Table 110. Glenmark Pharmaceuticals Company Information Table 111. Glenmark Pharmaceuticals Business Overview Table 112. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Portfolio Table 114. Glenmark Pharmaceuticals Recent Development Table 115. Genfit SA Company Information Table 116. Genfit SA Business Overview Table 117. Genfit SA Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Genfit SA Nuclear Receptor ROR Gamma Product Portfolio Table 119. Genfit SA Recent Development Table 120. Eurofins Advinus Company Information Table 121. Eurofins Advinus Business Overview Table 122. Eurofins Advinus Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Eurofins Advinus Nuclear Receptor ROR Gamma Product Portfolio Table 124. Eurofins Advinus Recent Development Table 125. Celgene Corp Company Information Table 126. Celgene Corp Business Overview Table 127. Celgene Corp Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Celgene Corp Nuclear Receptor ROR Gamma Product Portfolio Table 129. Celgene Corp Recent Development Table 130. Bristol-Myers Squibb Company Company Information Table 131. Bristol-Myers Squibb Company Business Overview Table 132. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Portfolio Table 134. Bristol-Myers Squibb Company Recent Development Table 135. Brickell Biotech Inc Company Information Table 136. Brickell Biotech Inc Business Overview Table 137. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Portfolio Table 139. Brickell Biotech Inc Recent Development Table 140. Aurigene Discovery Technologies Company Information Table 141. Aurigene Discovery Technologies Business Overview Table 142. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Portfolio Table 144. Aurigene Discovery Technologies Recent Development Table 145. AbbVie Inc Company Information Table 146. AbbVie Inc Business Overview Table 147. AbbVie Inc Nuclear Receptor ROR Gamma Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. AbbVie Inc Nuclear Receptor ROR Gamma Product Portfolio Table 149. AbbVie Inc Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Nuclear Receptor ROR Gamma Distributors List Table 153. Nuclear Receptor ROR Gamma Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Nuclear Receptor ROR Gamma Product Image Figure 2. Global Nuclear Receptor ROR Gamma Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nuclear Receptor ROR Gamma Market Size (2021-2032) & (US$ Million) Figure 4. Global Nuclear Receptor ROR Gamma Sales (2021-2032) & (W Units) Figure 5. Global Nuclear Receptor ROR Gamma Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Nuclear Receptor ROR Gamma Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. BBI-6000 Image Figure 9. R&D Progress Image Figure 10. INV-17 Image Figure 11. IMU-366 Image Figure 12. GSK-2981278 Image Figure 13. GRC-39815Action Image Figure 14. Others Image Figure 15. Global Nuclear Receptor ROR Gamma Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Nuclear Receptor ROR Gamma Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2021-2032) Figure 18. Global Nuclear Receptor ROR Gamma Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 19. Global Nuclear Receptor ROR Gamma Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2021-2032) Figure 21. Axial Spondyloarthritis Image Figure 22. Asthma Image Figure 23. Breast Cancer Image Figure 24. Chronic Obstructive Pulmonary Disease Image Figure 25. Others Image Figure 26. Global Nuclear Receptor ROR Gamma Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 27. Global Nuclear Receptor ROR Gamma Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2021-2032) Figure 29. Global Nuclear Receptor ROR Gamma Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 30. Global Nuclear Receptor ROR Gamma Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2021-2032) Figure 32. North America Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 33. North America Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2032) Figure 34. U.S. Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Canada Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Mexico Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Europe Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Europe Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2032) Figure 39. Germany Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 40. France Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 41. U.K. Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Italy Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Netherlands Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Asia Pacific Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Asia Pacific Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2032) Figure 46. China Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Japan Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Korea Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Southeast Asia Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 50. India Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Australia Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 52. South America, Middle East and Africa Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South America, Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share by Country (2021-2032) Figure 54. Brazil Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 55. South Africa Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Saudi Arabia Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Turkey Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Argentina Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 59. UAE Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Egypt Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 61. Chile Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2032) & (W Units) Figure 62. Global Nuclear Receptor ROR Gamma Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Figure 65. North America Nuclear Receptor ROR Gamma Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Figure 67. Europe Nuclear Receptor ROR Gamma Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Nuclear Receptor ROR Gamma Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Nuclear Receptor ROR Gamma Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Nuclear Receptor ROR Gamma Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Nuclear Receptor ROR Gamma Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Nuclear Receptor ROR Gamma Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • BBI-6000
  • R&D Progress
  • INV-17
  • IMU-366
  • GSK-2981278
  • GRC-39815Action
  • Others
Applications
  • Axial Spondyloarthritis
  • Asthma
  • Breast Cancer
  • Chronic Obstructive Pulmonary Disease
  • Others
Companies covered
  • Eli Lilly
  • GlaxoSmithKline Plc
  • Biogen Inc
  • Beijing Hanmi Pharmaceutical
  • Reata Pharmaceuticals Inc
  • Phenex Pharmaceuticals AG
  • Pfizer Inc
  • Lead Pharma Holding BV
  • Glenmark Pharmaceuticals
  • Genfit SA
  • Eurofins Advinus
  • Celgene Corp
  • Bristol-Myers Squibb Company
  • Brickell Biotech Inc
  • Aurigene Discovery Technologies
  • AbbVie Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nuclear Receptor ROR Gamma Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nuclear Receptor ROR Gamma Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nuclear Receptor ROR Gamma Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nuclear Receptor ROR Gamma Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nuclear Receptor ROR Gamma Market Dynamics
  1. 2.1 Nuclear Receptor ROR Gamma Industry Trends
  2. 2.2 Nuclear Receptor ROR Gamma Industry Drivers
  3. 2.3 Nuclear Receptor ROR Gamma Industry Opportunities and Challenges
  4. 2.4 Nuclear Receptor ROR Gamma Industry Restraints
3 Nuclear Receptor ROR Gamma Market by Manufacturers
  1. 3.1 Global Nuclear Receptor ROR Gamma Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nuclear Receptor ROR Gamma Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nuclear Receptor ROR Gamma Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nuclear Receptor ROR Gamma Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nuclear Receptor ROR Gamma Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nuclear Receptor ROR Gamma Manufacturers, Product Type & Application
  7. 3.7 Global Nuclear Receptor ROR Gamma Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nuclear Receptor ROR Gamma Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nuclear Receptor ROR Gamma Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nuclear Receptor ROR Gamma Tier 1, Tier 2, and Tier 3
4 Nuclear Receptor ROR Gamma Market by Type
  1. 4.1 Nuclear Receptor ROR Gamma Type Introduction
  2. 4.1.1 BBI-6000
  3. 4.1.2 R&D Progress
  4. 4.1.3 INV-17
  5. 4.1.4 IMU-366
  6. 4.1.5 GSK-2981278
  7. 4.1.6 GRC-39815Action
  8. 4.1.7 Others
  9. 4.2 Global Nuclear Receptor ROR Gamma Sales by Type
  10. 4.2.1 Global Nuclear Receptor ROR Gamma Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Nuclear Receptor ROR Gamma Sales by Type (2021-2032)
  12. 4.2.3 Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2021-2032)
  13. 4.3 Global Nuclear Receptor ROR Gamma Revenue by Type
  14. 4.3.1 Global Nuclear Receptor ROR Gamma Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Nuclear Receptor ROR Gamma Revenue by Type (2021-2032)
  16. 4.3.3 Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2021-2032)
5 Nuclear Receptor ROR Gamma Market by Application
  1. 5.1 Nuclear Receptor ROR Gamma Application Introduction
  2. 5.1.1 Axial Spondyloarthritis
  3. 5.1.2 Asthma
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Chronic Obstructive Pulmonary Disease
  6. 5.1.5 Others
  7. 5.2 Global Nuclear Receptor ROR Gamma Sales by Application
  8. 5.2.1 Global Nuclear Receptor ROR Gamma Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Nuclear Receptor ROR Gamma Sales by Application (2021-2032)
  10. 5.2.3 Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2021-2032)
  11. 5.3 Global Nuclear Receptor ROR Gamma Revenue by Application
  12. 5.3.1 Global Nuclear Receptor ROR Gamma Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Nuclear Receptor ROR Gamma Revenue by Application (2021-2032)
  14. 5.3.3 Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2021-2032)
6 Global Nuclear Receptor ROR Gamma Sales by Region
  1. 6.1 Global Nuclear Receptor ROR Gamma Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nuclear Receptor ROR Gamma Sales by Region (2021-2032)
  3. 6.2.1 Global Nuclear Receptor ROR Gamma Sales by Region (2021-2026)
  4. 6.2.2 Global Nuclear Receptor ROR Gamma Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nuclear Receptor ROR Gamma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nuclear Receptor ROR Gamma Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nuclear Receptor ROR Gamma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nuclear Receptor ROR Gamma Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nuclear Receptor ROR Gamma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nuclear Receptor ROR Gamma Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nuclear Receptor ROR Gamma Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nuclear Receptor ROR Gamma Revenue by Region
  1. 7.1 Global Nuclear Receptor ROR Gamma Revenue by Region
  2. 7.1.1 Global Nuclear Receptor ROR Gamma Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nuclear Receptor ROR Gamma Revenue by Region (2021-2026)
  4. 7.1.3 Global Nuclear Receptor ROR Gamma Revenue by Region (2027-2032)
  5. 7.1.4 Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nuclear Receptor ROR Gamma Revenue (2021-2032)
  8. 7.2.2 North America Nuclear Receptor ROR Gamma Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nuclear Receptor ROR Gamma Revenue (2021-2032)
  11. 7.3.2 Europe Nuclear Receptor ROR Gamma Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nuclear Receptor ROR Gamma Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nuclear Receptor ROR Gamma Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nuclear Receptor ROR Gamma Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nuclear Receptor ROR Gamma Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eli Lilly
  2. 8.1.1 Eli Lilly Company Information
  3. 8.1.2 Eli Lilly Business Overview
  4. 8.1.3 Eli Lilly Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eli Lilly Nuclear Receptor ROR Gamma Product Portfolio
  6. 8.1.5 Eli Lilly Recent Developments
  7. 8.2 GlaxoSmithKline Plc
  8. 8.2.1 GlaxoSmithKline Plc Company Information
  9. 8.2.2 GlaxoSmithKline Plc Business Overview
  10. 8.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Portfolio
  12. 8.2.5 GlaxoSmithKline Plc Recent Developments
  13. 8.3 Biogen Inc
  14. 8.3.1 Biogen Inc Company Information
  15. 8.3.2 Biogen Inc Business Overview
  16. 8.3.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biogen Inc Nuclear Receptor ROR Gamma Product Portfolio
  18. 8.3.5 Biogen Inc Recent Developments
  19. 8.4 Beijing Hanmi Pharmaceutical
  20. 8.4.1 Beijing Hanmi Pharmaceutical Company Information
  21. 8.4.2 Beijing Hanmi Pharmaceutical Business Overview
  22. 8.4.3 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Portfolio
  24. 8.4.5 Beijing Hanmi Pharmaceutical Recent Developments
  25. 8.5 Reata Pharmaceuticals Inc
  26. 8.5.1 Reata Pharmaceuticals Inc Company Information
  27. 8.5.2 Reata Pharmaceuticals Inc Business Overview
  28. 8.5.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Portfolio
  30. 8.5.5 Reata Pharmaceuticals Inc Recent Developments
  31. 8.6 Phenex Pharmaceuticals AG
  32. 8.6.1 Phenex Pharmaceuticals AG Company Information
  33. 8.6.2 Phenex Pharmaceuticals AG Business Overview
  34. 8.6.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Portfolio
  36. 8.6.5 Phenex Pharmaceuticals AG Recent Developments
  37. 8.7 Pfizer Inc
  38. 8.7.1 Pfizer Inc Company Information
  39. 8.7.2 Pfizer Inc Business Overview
  40. 8.7.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Inc Nuclear Receptor ROR Gamma Product Portfolio
  42. 8.7.5 Pfizer Inc Recent Developments
  43. 8.8 Lead Pharma Holding BV
  44. 8.8.1 Lead Pharma Holding BV Company Information
  45. 8.8.2 Lead Pharma Holding BV Business Overview
  46. 8.8.3 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Portfolio
  48. 8.8.5 Lead Pharma Holding BV Recent Developments
  49. 8.9 Glenmark Pharmaceuticals
  50. 8.9.1 Glenmark Pharmaceuticals Company Information
  51. 8.9.2 Glenmark Pharmaceuticals Business Overview
  52. 8.9.3 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Portfolio
  54. 8.9.5 Glenmark Pharmaceuticals Recent Developments
  55. 8.10 Genfit SA
  56. 8.10.1 Genfit SA Company Information
  57. 8.10.2 Genfit SA Business Overview
  58. 8.10.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Genfit SA Nuclear Receptor ROR Gamma Product Portfolio
  60. 8.10.5 Genfit SA Recent Developments
  61. 8.11 Eurofins Advinus
  62. 8.11.1 Eurofins Advinus Company Information
  63. 8.11.2 Eurofins Advinus Business Overview
  64. 8.11.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Eurofins Advinus Nuclear Receptor ROR Gamma Product Portfolio
  66. 8.11.5 Eurofins Advinus Recent Developments
  67. 8.12 Celgene Corp
  68. 8.12.1 Celgene Corp Company Information
  69. 8.12.2 Celgene Corp Business Overview
  70. 8.12.3 Celgene Corp Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Celgene Corp Nuclear Receptor ROR Gamma Product Portfolio
  72. 8.12.5 Celgene Corp Recent Developments
  73. 8.13 Bristol-Myers Squibb Company
  74. 8.13.1 Bristol-Myers Squibb Company Company Information
  75. 8.13.2 Bristol-Myers Squibb Company Business Overview
  76. 8.13.3 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Portfolio
  78. 8.13.5 Bristol-Myers Squibb Company Recent Developments
  79. 8.14 Brickell Biotech Inc
  80. 8.14.1 Brickell Biotech Inc Company Information
  81. 8.14.2 Brickell Biotech Inc Business Overview
  82. 8.14.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Portfolio
  84. 8.14.5 Brickell Biotech Inc Recent Developments
  85. 8.15 Aurigene Discovery Technologies
  86. 8.15.1 Aurigene Discovery Technologies Company Information
  87. 8.15.2 Aurigene Discovery Technologies Business Overview
  88. 8.15.3 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Portfolio
  90. 8.15.5 Aurigene Discovery Technologies Recent Developments
  91. 8.16 AbbVie Inc
  92. 8.16.1 AbbVie Inc Company Information
  93. 8.16.2 AbbVie Inc Business Overview
  94. 8.16.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 AbbVie Inc Nuclear Receptor ROR Gamma Product Portfolio
  96. 8.16.5 AbbVie Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nuclear Receptor ROR Gamma Value Chain Analysis
  2. 9.1.1 Nuclear Receptor ROR Gamma Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nuclear Receptor ROR Gamma Production Mode & Process
  6. 9.2 Nuclear Receptor ROR Gamma Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nuclear Receptor ROR Gamma Distributors
  9. 9.2.3 Nuclear Receptor ROR Gamma Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst